Literature DB >> 8282783

Increased production of nitric oxide in coronary arteries during congestive heart failure.

B O'Murchu1, V M Miller, M A Perrella, J C Burnett.   

Abstract

Experiments were designed to determine whether a heterogeneity of endothelium-dependent relaxations in arteries from different vascular beds exists in experimental congestive heart failure (CHF) and to determine the mediators of those responses. CHF was produced in dogs by rapid ventricular pacing for 15 d. Rings of coronary, femoral, and renal arteries with and without endothelium from control and CHF dogs were suspended in organ chambers for measurement of isometric force. In arteries contracted with prostaglandin F2 alpha, endothelium-dependent relaxations to BHT 920 (an alpha 2-adrenergic agonist) were increased in coronary arteries from dogs with CHF (maximal relaxation: control -15 +/- 9% vs CHF -92 +/- 5%; n = 5-6; P < 0.05), with a modest enhancement in renal arteries. Relaxations to adenosine diphosphate and the calcium ionophore were unchanged. Relaxations to BHT 920 in CHF were reduced by NG monomethyl-L-arginine (L-NMMA) and pertussis toxin but not by indomethacin. These data suggest that endothelium-dependent relaxations are affected heterogeneously in CHF. The enhanced response to alpha 2-adrenergic agonists in the coronary artery is mediated by nitric oxide through a mechanism sensitive to inhibition by pertussis toxin. This selective increase in endothelium-dependent relaxations in the coronary artery may contribute to preserving coronary blood flow during CHF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8282783      PMCID: PMC293749          DOI: 10.1172/JCI116940

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Exercise and heart disease; a study in regional circulation.

Authors:  K W DONALD
Journal:  Br Med J       Date:  1959-04-18

2.  Effect of isoproterenol on coronary blood flow in primary myocardial disease.

Authors:  L D Horwitz; G C Curry; R W Parkey; F J Bonte
Journal:  Circulation       Date:  1974-09       Impact factor: 29.690

Review 3.  G protein involvement in receptor-effector coupling.

Authors:  P J Casey; A G Gilman
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

5.  Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein.

Authors:  H Shimokawa; N A Flavahan; P M Vanhoutte
Journal:  Circ Res       Date:  1989-09       Impact factor: 17.367

6.  Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure.

Authors:  H Drexler; W Lu
Journal:  Am J Physiol       Date:  1992-06

7.  Heart failure depresses endothelium-dependent responses in canine femoral artery.

Authors:  L Kaiser; R C Spickard; N B Olivier
Journal:  Am J Physiol       Date:  1989-04

8.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

9.  Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin.

Authors:  T M Cocks; J A Angus
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

10.  Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy.

Authors:  C B Treasure; J A Vita; D A Cox; R D Fish; J B Gordon; G H Mudge; W S Colucci; M G Sutton; A P Selwyn; R W Alexander
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

View more
  7 in total

1.  The role of nitric oxide in heart failure. Potential for pharmacological intervention.

Authors:  P Macdonald; C Schyvens; D Winlaw
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

Review 2.  The role of nitric oxide in the failing heart.

Authors:  W J Paulus
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

3.  Interaction of nitric oxide synthase inhibitors and their D-enantiomers with rat neutrophil luminol dependent chemiluminescence response.

Authors:  M Dikshit; S S Chari; P Seth; R Kumari
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

4.  Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery.

Authors:  S Salomone; C L Silva; N Morel; T Godfraind
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

Review 5.  Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications.

Authors:  Lei Xi; Shu-Guang Zhu; Anindita Das; Qun Chen; David Durrant; Daniel C Hobbs; Edward J Lesnefsky; Rakesh C Kukreja
Journal:  Nitric Oxide       Date:  2012-04-05       Impact factor: 4.427

6.  Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.

Authors:  Shu-Guang Zhu; Rakesh C Kukreja; Anindita Das; Qun Chen; Edward J Lesnefsky; Lei Xi
Journal:  J Am Coll Cardiol       Date:  2011-05-24       Impact factor: 24.094

Review 7.  The TNF-α/sphingosine-1-phosphate signaling axis drives myogenic responsiveness in heart failure.

Authors:  Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Vasc Res       Date:  2013-04-16       Impact factor: 1.934

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.